ProGeLife is developing innovative
treatments for rare diseases
with premature aging





An excellent R&D team focuses its research on two extremely rare genetic diseases of children characterized by accelerated or premature aging: ProgeriaProgeria : This paradigmatic disease of aging is also known as Hutchinson-Gilford syndrome. Extremely rare genetic disease (aroung 300 living patients worldwide) characterized by an accelerated and premature aging due to the abnormal accumulation of progerin. and Xeroderma pigmentosumXeroderma pigmentosum : A group of rare genetic diseases characterized by a defect in one of the DNA repair pathways. Depending on the mutated protein, eight XP diseases are known, XPA to XPG and XPV. (the "Children of the Moon" disease).



ProGeLife is patenting and developing innovative and adapted treatments:

  • in the first instance to the paediatric population
  • further applied to age-related diseases that are more common in the general population.